Hepatocellular carcinoma (HCC) is a frequent end-stage outcome of many chronic liver diseases, such as viral hepatitis and alcoholic liver disease, and of exposure to chemical carcinogens. The development of liver cancer is a slow process that involves multiple stages of initiation, promotion and progression, encompassing a long period. Molecular events controlling the process have not been fully elucidated, particularly at the early stage of tumor initiation. In a chemical hepatocarcinogenic model employing the classical carcinogen, diethylnitrosamine, we found that deletion of Bid, a pro-death Bcl-2 family protein, paradoxically suppressed the carcinogenesis starting at the early stage of microfoci development, when the capability of hepatocyte proliferation is critically involved. This early effect had a significant impact on overall tumor development examined 8-12 months after diethylnitrosamine administration. Further studies revealed a novel function of Bid in promotion of cell cycle entry and in regulation of intracellular calcium homeostasis. We hypothesize that Bid facilitates the initiation of tumorigenesis by promoting cell proliferation but also exert its pro-apoptosis function in the later stage of tumor development. We are proposing to test this hypothesis through the following approaches: 1) Examination of the effect of Bid in DEN-induced liver tumor paradigms and in mice of different genetic backgrounds that are known to affect the tumor initiation and cell proliferation capability;2) Determination of the stage-specific effect of Bid on tumor development based on its function in cell proliferation and cell death using inducible transgenic and gene deletion models;3) Exploration of the mechanisms of Bid in regulating cell cycle progression via its effects on calcium homeostasis in endoplasmic reticulum. We hope that these studies will allow us to achieve our long term goal of understanding how the growth potential of cells affects chemical carcinogenesis, particularly in the liver system, and how this potential is regulated by different genetic elements.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA111456-06
Application #
8237696
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
2005-07-01
Project End
2012-05-31
Budget Start
2011-07-29
Budget End
2012-05-31
Support Year
6
Fiscal Year
2009
Total Cost
$99,002
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Pathology
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Li, M; Fu, Y; Yang, Z et al. (2017) Measurement of the Activity of the Atg4 Cysteine Proteases. Methods Enzymol 587:207-225
Gao, Ying; Liu, Yajun; Hong, Liang et al. (2016) Golgi-associated LC3 lipidation requires V-ATPase in noncanonical autophagy. Cell Death Dis 7:e2330
Yu, Changshun; Yan, Shengmin; Khambu, Bilon et al. (2016) Gene Expression Analysis Indicates Divergent Mechanisms in DEN-Induced Carcinogenesis in Wild Type and Bid-Deficient Livers. PLoS One 11:e0155211
Li, Min; Yang, Zuolong; Vollmer, Laura L et al. (2015) AMDE-1 is a dual function chemical for autophagy activation and inhibition. PLoS One 10:e0122083
Gallo, Luciana I; Liao, Yong; Ruiz, Wily G et al. (2014) TBC1D9B functions as a GTPase-activating protein for Rab11a in polarized MDCK cells. Mol Biol Cell 25:3779-97
Chen, Xi; Khambu, Bilon; Zhang, Hao et al. (2014) Autophagy induced by calcium phosphate precipitates targets damaged endosomes. J Biol Chem 289:11162-74
Akin, Debra; Wang, S Keisin; Habibzadegah-Tari, Pouran et al. (2014) A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors. Autophagy 10:2021-35
Chen, Daohong; Chen, Xi; Li, Min et al. (2013) CCCP-Induced LC3 lipidation depends on Atg9 whereas FIP200/Atg13 and Beclin 1/Atg14 are dispensable. Biochem Biophys Res Commun 432:226-30
Li, Min; Khambu, Bilon; Zhang, Hao et al. (2013) Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity. J Biol Chem 288:35769-80
Lin, Chih-Wen; Zhang, Hao; Li, Min et al. (2013) Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice. J Hepatol 58:993-9

Showing the most recent 10 out of 37 publications